VF
TGTX icon

Virtu Financial’s TG Therapeutics TGTX Stock Holding History

Virtu Financial’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,224
Closed -$319K – 2036
2023
Q1 		$319K Buy
+21,224
New +$322K 0.03% 519
2022
Q3 		– Sell
-12,191
Closed -$52K – 2236
2022
Q2 		$52K Sell
12,191
-8,374
-41% -$52.3K ﹤0.01% 1118
2022
Q1 		$196K Buy
+20,565
New +$238K 0.01% 789
2021
Q3 		– Sell
-6,493
Closed -$252K – 1956
2021
Q2 		$252K Buy
+6,493
New +$255K 0.02% 830
2021
Q1 		– Sell
-17,330
Closed -$902K – 2017
2020
Q4 		$902K Buy
+17,330
New +$586K 0.1% 254
2020
Q3 		– Sell
-10,477
Closed -$204K – 1505
2020
Q2 		$204K Buy
+10,477
New +$169K 0.02% 721
2019
Q4 		$361K Buy
32,551
+20,278
+165% +$154K 0.04% 579
2019
Q3 		$69K Buy
+12,273
New +$85.6K 0.01% 1145
2019
Q1 		– Sell
-51,570
Closed -$211K – 1834
2018
Q4 		$211K Buy
51,570
+41,245
+399% +$205K 0.01% 932
2018
Q3 		$58K Buy
+10,325
New +$118K ﹤0.01% 1280
2018
Q2 		– Sell
-36,592
Closed -$520K – 2493
2018
Q1 		$520K Sell
36,592
-9,463
-21% -$121K 0.03% 682
2017
Q4 		$378K Buy
46,055
+25,943
+129% +$227K 0.02% 1068
2017
Q3 		$238K Buy
+20,112
New +$229K 0.01% 1635

Other funds holding TGTX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Virtu Financial's TGTX Position: Q2 2023 in Review

Virtu Financial sold out of TG Therapeutics (TGTX) in Q2 2023, closing a stake of 21,224 shares — an estimated $319K sold.

Virtu Financial first reported a position in TGTX in Q3 2017 and held it in 13 quarters. The position peaked at $902K in Q4 2020. 244 funds tracked by Wall St. Rank hold TGTX as of Q2 2023.

  • Virtu Financial reported no remaining TG Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Virtu Financial sold 21,224 TG Therapeutics shares in Q2 2023, an estimated $319K.
  • Virtu Financial first reported a position in TG Therapeutics in Q3 2017 and held it in 13 quarters.
  • Virtu Financial's TG Therapeutics position peaked at $902K in Q4 2020.
  • 244 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2023.

Based on Virtu Financial's 13F filing for Q2 2023, filed 27 Jul 2023.